Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?

Cancer Biology and Therapy

Volumn 9, Issue 8, 2010, Pages 615-617

  Roh, Meejeon ^a   Abdulkadir, Sarki A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrasentan; Bone metastasis; Endothelin; Mouse model; Prostate cancer

Indexed keywords

ATRASENTAN; DOCETAXEL; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; APOPTOSIS; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER PAIN; CELL PROLIFERATION; IN VIVO STUDY; NONHUMAN; NOTE; OSTEOBLAST; OSTEOCLAST; PROSTATE CANCER; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

EID: 77953710854     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.8.11309     Document Type: Note

References (25)

1. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003; 3:110-6.
2. Bagnato A, Rosano L. The endothelin axis in cancer. Int J Biochem Cell Biol 2003; 40:1443-51.
3. Chung KY, Walker JW. Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart. Mol Pharmacol 2007; 71:1494-502.
4. Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ. Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 1997; 328:733-7. (Pubitemid 28005768)
5. Salani D, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000; 157:1703-11.
6. Salani D, et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000; 157:1537-47.
7. Nelson JB, et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995; 1:944-9.
8. Nelson JB, et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996; 56:663-8.
9. Yin JJ, et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA 2003; 100:10954-9.
10. Banerjee S, et al. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Res 2007; 67:3818-26.
11. Carducci MA, et al. Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics. J Clin Oncol 2002; 20:2171-80.
12. Carducci MA, et al. Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. J Clin Oncol 2003; 21:679-89.
13. Nelson JB, et al. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. J Urol 2003; 169:1143-9.
14. Carducci MA, et al. A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. Cancer 2007; 110:1959-66.
15. Nelson JB, et al. Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer. Cancer 2008; 113:2478-87.
16. Dawson NA. Targeted therapy in prostate cancer - are we our own worst enemy? Cancer 2008; 113:2376-8.
17. Akhavan A, et al. Endothelin receptor A blockade enhances taxane effects in prostate cancer. Neoplasia 2006; 8:725-32.
18. Armstrong AJ, et al. A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer. Clin Cancer Res 2008; 14:6270-6.
19. Drake JM, Danke JR, Henry MD. Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan. Cancer Biol Ther 2010; This issue.
20. Drake JM, Gabriel CL, Henry MD. Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging. Clin Exp Metastasis 2005; 22:674-84.
21. Weydert CJ, et al. Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles. Cancer Biol Ther 2009; 8:720-9.
22. Pedram A, Razandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997; 272:17097-103.
23. Wendel M, Knels L, Kummer W, Koch T. Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney. J Histochem Cytochem 2006; 54:1193-203.
24. Dehouck MP, et al. Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab 1997; 17:464-9.
25. Bagnato A, Spinella F. Emerging role of endothelin-1 in tumor angiogenesis. Trends Endocrinol Metab 2003; 14:44-50.